A Victorian coroner has called on the TGA to consider a ban on prescribing unapproved peptides after a 75-year-old man died from complications of a cardiac arrest after injecting the experimental ...

A frontline chemotherapy-free strategy using a tyrosine kinase inhibitor and immunotherapy beats the conventional chemotherapy approach for treating Philadelphia-positive acute lymphoblastic leukaemia ...

Brentuximab vedotin (Adcetris, Takeda) is now on the PBS as part of the multi-drug BrECADD chemotherapy regimen for front-line treatment in adult patients with advanced stage CD30+ Hodgkin lymphoma.

JAK inhibitors should be an option for symptomatic myelofibrosis patients even if their disease is low risk, according to new guidelines from the American Society of Hematology (ASH). Published in ...

The addition of metastatic-directed therapy (MDT) to standard of care systemic therapy in patients with oligometastatic disease improves PFS in a range of cancers. The phase 2 EXTEND basket trial, ...

The image of the wise and skilful healer has driven countless clinicians to dedicate their lives to the profession, but that ...

GLP-1/GIP RAs are associated with a modest and borderline reduction in the risk of progression to advanced kidney disease compared with finerenone in people with type 2 diabetes and moderate kidney ...

Australia leads the way when it comes to home dialysis uptake, alongside neighbour New Zealand, compared with other high-income countries, a multi-registry study has shown. The INTEGRATED research ...

Clinicians who fail to manage commercial conflicts of interest when treating patients face fines up of to $120,000, Ahpra has warned. The regulator has published new interim guidance for practitioners ...

News that one of Australia’s leading medical research institutes is set to cease operations as an independent entity due to funding issues has set alarm bells ringing about the future of Australia’s ...

Join an expert panel of QLD oncologists as they present their selection of transformational clinical data in breast, lung, GU, GI and skin cancers from the ESMO Congress 2026 and discuss the impacts ...

Digoxin is associated with better long-term cardiovascular outcomes than beta-blockers in patients with atrial fibrillation and symptoms of heart failure, research has found. The study presented at ...